As per Intent Market Research, the Consumer Genomics Market was valued at USD 3.9 Billion in 2024-e and will surpass USD 9.3 Billion by 2030; growing at a CAGR of 15.6% during 2025 - 2030.
The consumer genomics market is witnessing significant growth, driven by increasing consumer interest in personalized health and wellness solutions. As advancements in genomics and biotechnology have made genetic testing more accessible, individuals are increasingly seeking ways to understand their genetic makeup for a variety of purposes, such as ancestry exploration, health risk assessment, and personalized medicine. The direct-to-consumer (DTC) model has played a pivotal role in revolutionizing the market, allowing consumers to access genetic testing services without the need for healthcare professionals to be involved. With rising consumer awareness about genetic health risks and the desire for personalized insights, the consumer genomics market is poised for continued expansion.
Genetic Testing Kits Are Leading the Market Due to Consumer Interest in Ancestry and Wellness
Genetic testing kits are the largest product category in the consumer genomics market, driven by consumer curiosity about ancestry, ethnicity, and health. These kits offer individuals the ability to easily collect genetic material at home, often through a simple saliva or cheek swab sample, which is then analyzed to provide insights into genetic traits, ancestral origins, and health risks. The growing popularity of ancestry and ethnicity testing has made genetic testing kits a highly sought-after product among consumers looking to connect with their heritage or uncover previously unknown family history.
Furthermore, as awareness of health risks linked to genetic predispositions increases, consumers are turning to genetic testing kits to gain insights into conditions such as heart disease, cancer, and genetic disorders. With the ability to make proactive health decisions based on genetic data, the demand for genetic testing kits is expected to continue to rise, making them the leading product in the consumer genomics market.
.JPG)
Health and Wellness Application Drives Market Growth
The health and wellness application is the fastest-growing segment in the consumer genomics market, as more individuals look to leverage genetic information for maintaining a healthy lifestyle. With the increasing availability of genetic tests that reveal predispositions to conditions like obesity, diabetes, and cardiovascular disease, consumers are becoming more proactive about their health. Genetic testing provides insights that help individuals make informed decisions regarding diet, exercise, and lifestyle habits that align with their unique genetic makeup.
Personalized health recommendations based on genetic data are revolutionizing wellness programs, as individuals can now tailor their health strategies to optimize outcomes. This trend is expected to accelerate as more consumers seek to optimize their health based on their genetic predispositions, fueling further growth in the health and wellness application of consumer genomics.
North America Leads the Market Due to High Adoption Rates and Technological Advancements
North America holds the largest market share in the consumer genomics industry, primarily due to the high adoption rate of genetic testing services and advancements in genomics technologies. The United States, in particular, has seen widespread acceptance of genetic testing, with companies like 23andMe and Ancestry.com leading the way in providing direct-to-consumer services. The presence of a large number of established genomics companies, coupled with the increasing demand for personalized health solutions, has positioned North America as the dominant market for consumer genomics.
The regulatory environment in the region also supports market growth, as policies are being developed to ensure consumer protection and data privacy. With the continued innovation in genomics technologies and the rise in consumer demand for personalized healthcare solutions, North America is expected to maintain its leadership position in the global consumer genomics market.
.JPG)
Competitive Landscape
The consumer genomics market is highly competitive, with a variety of players offering genetic testing services and related products. Leading companies in the market include 23andMe, Ancestry.com, MyHeritage, and Color Genomics. These companies are focusing on expanding their product portfolios and enhancing customer experiences through improved testing accuracy, faster turnaround times, and user-friendly interfaces.
In addition to genetic testing providers, genomic data analysis services are becoming increasingly important as consumers look to interpret and act on their genetic information. Companies are also leveraging partnerships with healthcare providers to expand into personalized medicine, offering more advanced insights and tailored health plans based on genetic data. As the market continues to evolve, competition is expected to intensify, with innovation in testing methods, data analysis, and customer engagement driving the next phase of growth.
List of Leading Companies:
- 23andMe
- Ancestry.com
- MyHeritage
- Veritas Genetics
- Living DNA
- Helix
- Color Genomics
- DNAfit
- Fulgent Genetics
- Quest Diagnostics
- LabCorp
- Gene by Gene
- SNPedia
- Everlywell
- EasyDNA
Recent Developments:
- 23andMe launched a new health risk assessment service in January 2025, allowing consumers to access reports on genetic predispositions for common diseases.
- Ancestry.com partnered with major research institutions in December 2024 to enhance its ancestry testing capabilities with deeper genetic insights.
- MyHeritage introduced a new DNA testing kit in November 2024, aimed at providing more detailed ethnic and geographical heritage information.
- Living DNA expanded its health and wellness offerings in October 2024, now providing genetic wellness reports for improved lifestyle guidance.
- Helix unveiled a subscription-based genomics platform in September 2024, offering personalized health insights and continuous genomic tracking.
Report Scope:
|
Report Features |
Description |
|
Market Size (2024-e) |
USD 3.9 Billion |
|
Forecasted Value (2030) |
USD 9.3 Billion |
|
CAGR (2025 – 2030) |
15.6% |
|
Base Year for Estimation |
2024-e |
|
Historic Year |
2023 |
|
Forecast Period |
2025 – 2030 |
|
Report Coverage |
Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments |
|
Segments Covered |
Consumer Genomics Market By Product Type (Genetic Testing Kits, Genomic Data Analysis Services), By Technology (Direct-to-Consumer, Laboratory-Based Testing), By Application (Ancestry and Ethnicity, Health and Wellness, Personalized Medicine), and By End-User Industry (Healthcare and Wellness, Direct-to-Consumer Services) |
|
Regional Analysis |
North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa) |
|
Major Companies |
23andMe, Ancestry.com, MyHeritage, Veritas Genetics, Living DNA, Helix, DNAfit, Fulgent Genetics, Quest Diagnostics, LabCorp, Gene by Gene, SNPedia, EasyDNA |
|
Customization Scope |
Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements |
Frequently Asked Questions
The Consumer Genomics Market was valued at USD 3.9 Billion in 2024-e and is expected to grow at a CAGR of 15.6% of over from 2025 to 2030.
Consumer genomics refers to the use of genetic testing and analysis by individuals to understand their ancestry, health risks, and genetic traits through direct-to-consumer services.
These kits allow consumers to provide a saliva or cheek swab sample, which is then analyzed to provide information on ancestry, health conditions, or genetic traits.
Consumer genomics can help assess genetic risks for diseases, offer personalized health recommendations, and even guide lifestyle choices based on genetic predispositions.
DTC genetic testing allows consumers to directly purchase genetic testing kits without the need for a healthcare provider, usually involving ancestry or health-related tests.
|
1. Introduction |
|
1.1. Market Definition |
|
1.2. Scope of the Study |
|
1.3. Research Assumptions |
|
1.4. Study Limitations |
|
2. Research Methodology |
|
2.1. Research Approach |
|
2.1.1. Top-Down Method |
|
2.1.2. Bottom-Up Method |
|
2.1.3. Factor Impact Analysis |
|
2.2. Insights & Data Collection Process |
|
2.2.1. Secondary Research |
|
2.2.2. Primary Research |
|
2.3. Data Mining Process |
|
2.3.1. Data Analysis |
|
2.3.2. Data Validation and Revalidation |
|
2.3.3. Data Triangulation |
|
3. Executive Summary |
|
3.1. Major Markets & Segments |
|
3.2. Highest Growing Regions and Respective Countries |
|
3.3. Impact of Growth Drivers & Inhibitors |
|
3.4. Regulatory Overview by Country |
|
4. Consumer Genomics Market, by Product Type (Market Size & Forecast: USD Million, 2023 – 2030) |
|
4.1. Genetic Testing Kits |
|
4.2. Genomic Data Analysis Services |
|
5. Consumer Genomics Market, by Technology (Market Size & Forecast: USD Million, 2023 – 2030) |
|
5.1. Direct-to-Consumer (DTC) |
|
5.2. Laboratory-Based Testing |
|
6. Consumer Genomics Market, by Application (Market Size & Forecast: USD Million, 2023 – 2030) |
|
6.1. Ancestry and Ethnicity |
|
6.2. Health and Wellness |
|
6.3. Personalized Medicine |
|
7. Consumer Genomics Market, by End-User Industry (Market Size & Forecast: USD Million, 2023 – 2030) |
|
7.1. Healthcare and Wellness |
|
7.2. Direct-to-Consumer Services |
|
8. Regional Analysis (Market Size & Forecast: USD Million, 2023 – 2030) |
|
8.1. Regional Overview |
|
8.2. North America |
|
8.2.1. Regional Trends & Growth Drivers |
|
8.2.2. Barriers & Challenges |
|
8.2.3. Opportunities |
|
8.2.4. Factor Impact Analysis |
|
8.2.5. Technology Trends |
|
8.2.6. North America Consumer Genomics Market, by Product Type |
|
8.2.7. North America Consumer Genomics Market, by Technology |
|
8.2.8. North America Consumer Genomics Market, by Application |
|
8.2.9. North America Consumer Genomics Market, by End-User Industry |
|
8.2.10. By Country |
|
8.2.10.1. US |
|
8.2.10.1.1. US Consumer Genomics Market, by Product Type |
|
8.2.10.1.2. US Consumer Genomics Market, by Technology |
|
8.2.10.1.3. US Consumer Genomics Market, by Application |
|
8.2.10.1.4. US Consumer Genomics Market, by End-User Industry |
|
8.2.10.2. Canada |
|
8.2.10.3. Mexico |
|
*Similar segmentation will be provided for each region and country |
|
8.3. Europe |
|
8.4. Asia-Pacific |
|
8.5. Latin America |
|
8.6. Middle East & Africa |
|
9. Competitive Landscape |
|
9.1. Overview of the Key Players |
|
9.2. Competitive Ecosystem |
|
9.2.1. Level of Fragmentation |
|
9.2.2. Market Consolidation |
|
9.2.3. Product Innovation |
|
9.3. Company Share Analysis |
|
9.4. Company Benchmarking Matrix |
|
9.4.1. Strategic Overview |
|
9.4.2. Product Innovations |
|
9.5. Start-up Ecosystem |
|
9.6. Strategic Competitive Insights/ Customer Imperatives |
|
9.7. ESG Matrix/ Sustainability Matrix |
|
9.8. Manufacturing Network |
|
9.8.1. Locations |
|
9.8.2. Supply Chain and Logistics |
|
9.8.3. Product Flexibility/Customization |
|
9.8.4. Digital Transformation and Connectivity |
|
9.8.5. Environmental and Regulatory Compliance |
|
9.9. Technology Readiness Level Matrix |
|
9.10. Technology Maturity Curve |
|
9.11. Buying Criteria |
|
10. Company Profiles |
|
10.1. 23andMe |
|
10.1.1. Company Overview |
|
10.1.2. Company Financials |
|
10.1.3. Product/Service Portfolio |
|
10.1.4. Recent Developments |
|
10.1.5. IMR Analysis |
|
*Similar information will be provided for other companies |
|
10.2. Ancestry.com |
|
10.3. MyHeritage |
|
10.4. Veritas Genetics |
|
10.5. Living DNA |
|
10.6. Helix |
|
10.7. Color Genomics |
|
10.8. DNAfit |
|
10.9. Fulgent Genetics |
|
10.10. Quest Diagnostics |
|
10.11. LabCorp |
|
10.12. Gene by Gene |
|
10.13. SNPedia |
|
10.14. Everlywell |
|
10.15. EasyDNA |
|
11. Appendix |
A comprehensive market research approach was employed to gather and analyze data on the Consumer Genomics Market . In the process, the analysis was also done to analyze the parent market and relevant adjacencies to measure the impact of them on the Consumer Genomics Market . The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.
.jpg)
Secondary Research
Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.
Primary Research
Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the E-Waste Management ecosystem. The primary research objectives included:
- Validating findings and assumptions derived from secondary research
- Gathering qualitative and quantitative data on market trends, drivers, and challenges
- Understanding the demand-side dynamics, encompassing end-users, component manufacturers, facility providers, and service providers
- Assessing the supply-side landscape, including technological advancements and recent developments
Market Size Assessment
A combination of top-down and bottom-up approaches was utilized to analyze the overall size of the Consumer Genomics Market . These methods were also employed to assess the size of various subsegments within the market. The market size assessment methodology encompassed the following steps:
- Identification of key industry players and relevant revenues through extensive secondary research
- Determination of the industry's supply chain and market size, in terms of value, through primary and secondary research processes
- Calculation of percentage shares, splits, and breakdowns using secondary sources and verification through primary sources
.jpg)
Data Triangulation
To ensure the accuracy and reliability of the market size, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size assessment.